CTIC : Summary for CTI BioPharma Corp. - Yahoo Finance

U.S. Markets close in 32 mins.

CTI BioPharma Corp. (CTIC)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.27-0.19 (-4.26%)
As of 3:26PM EST. Market open.
People also watch
AGENHEBXOMAKERXARIA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close4.46
Open4.41
Bid4.26 x 300
Ask4.27 x 300
Day's Range4.25 - 4.41
52 Week Range0.31 - 6.48
Volume122,857
Avg. Volume774,644
Market Cap120.53M
Beta0.98
PE Ratio (TTM)-1.53
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire15 days ago

    CTI BioPharma to Present at the BIO CEO & Investor Conference

    SEATTLE, Feb. 8, 2017 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced that management will present at the the BIO CEO & Investor Conference on Tuesday, February ...

  • PR Newswire29 days ago

    CTI BioPharma Appoints Leading BioPharma Executive Michael Metzger To Board Of Directors

    SEATTLE, Jan. 24, 2017 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced that Michael A. Metzger has been appointed a Director of CTI BioPharma. Mr. Metzger brings extensive experience leading and growing companies in the biopharmaceutical industry over the last 20 years. "We are pleased to welcome Michael to the Board of CTI BioPharma," said Richard Love, Interim President and CEO of CTI BioPharma.

  • Accesswirelast month

    Latest Reports on Recent Market Movers: 3D Systems and CTI BioPharma

    NEW YORK, NY / ACCESSWIRE / January 10, 2017 / The Dow Jones Industrial Average pulled back Monday after nearly breaking the 20,000 point plateau Friday. Declines by financial and energy sectors pressured ...